Results 191 to 200 of about 22,143,644 (312)
Walking Capacity in Parkinson's Disease: Test-Retest Reliability of the 6-min Walk Test on a Non-Linear Circuit. [PDF]
Mayoral-Moreno A +5 more
europepmc +1 more source
Targeting the noradrenergic‐metabolic axis: A new strategy for sugar‐induced depression subtypes
Abstract Background and Purpose Lifestyle is closely related to major depressive disorder (MDD). Given the growing focus on the impact of diet on mental health, this study examined how dietary habits affect the pathophysiology of MDD. Experimental Approach Health check‐up data were analysed. Mice received sucrose under chronic unpredictable mild stress
Takatoshi Sakata +13 more
wiley +1 more source
Does Duty Cycle Modification Affect Temperature During Thulium Fiber Laser Lithotripsy? [PDF]
Richards K +8 more
europepmc +1 more source
Abstract Aim To identify the standardized instruments used to assess mobility aspects in children and adolescents with autism spectrum disorder (ASD), analyse the quality of their psychometric properties and their level of evidence, and develop a clinical decision map for these instruments.
Arthur Felipe Barroso de Lima +4 more
wiley +1 more source
Network dynamics of metabolic disease continuum in older adults: a 7-year longitudinal cohort study in China. [PDF]
Xu G, Song Q, Jia M, Yu Y, Su S, Mao J.
europepmc +1 more source
The HADES alignment strategy [PDF]
Markert, J., Pechenov, V., Pechenova, O.
core +1 more source
Objetivos Identificar os instrumentos padronizados usados para avaliar aspectos de mobilidade em crianças e adolescentes com transtorno do espectro autista (TEA), analisar a qualidade de suas propriedades psicométricas e seu nível de evidência, e desenvolver um mapa de decisão clínica para esses instrumentos.
Arthur Felipe Barroso de Lima +4 more
wiley +1 more source
Can You Trust Your Strength Assessment? Evaluating the Reliability and Validity of Handheld and Externally Fixated Dynamometers for Measuring Knee and Hip Strength. [PDF]
Depuydt LR +3 more
europepmc +1 more source
Abstract Objectives Drug‐resistant epilepsy (DRE) remains a major clinical challenge, affecting approximately one‐third of patients with epilepsy. Cenobamate, a novel antiseizure medication (ASM) approved in Italy in 2022, has shown promise in clinical trials. However, real‐world data on its use, especially economic evaluations, remain limited.
Valentina Perrone +27 more
wiley +1 more source

